New research evaluates clinical trials investigating post-acute COVID-19 syndrome treatment

In a recent article published in Clinical Microbiology and Infection, researchers reviewed all registered trials currently investigating potential treatment options for post-acute coronavirus disease 2019 (COVID-19) syndrome (PACS).

COVID-19 infection: an overview on cytokine storm and related interventions, Virology Journal

Frontiers Psychophysical therapy and underlying neuroendocrine mechanisms for the rehabilitation of long COVID-19

Delay or Avoidance of Medical Care Because of COVID-19–Related Concerns — United States, June 2020

The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID

Cell therapy strategies for COVID-19: Current approaches and potential applications

Long COVID NIH COVID-19 Research

The NIH poured $1 billion into long Covid research, with little to show for it

Does BCG vaccination protect against acute respiratory infections and COVID- 19? A rapid review of current evidence - The Centre for Evidence-Based Medicine

Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID- 19: JACC State-of-the-Art Review - ScienceDirect

Clinical trials of hydroxychloroquine in COVID19 outpatients reported as safe

Annual Report to the Nation Part 2 pandemic cancer diagnoses - NCI

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Long COVID and cardiovascular disease: a learning health system approach

A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: an international Delphi consensus study - The Lancet Respiratory Medicine